Discover 161 paid clinical trials in Augusta, Maine. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 161
Active & Responsive
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
for
Metastatic Breast Cancer
Location: Augusta ME, Brewer ME, Methuen MA, Boston MA, Weymouth MA,
Sponsor: American Society of Clinical Oncology
Sex: All
Age: 65+
Code: NCT06377852
Phase3, Recruiting
Active & Responsive
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
for
Breast Cancer
Location: Portland ME, Albany NY, Waterbury CT, Mount Kisco NY,
Sponsor: Agendia
Sex: All
Age: 18+
Code: NCT03053193
Recruiting
Active & Responsive
Percutaneous or Surgical Repair In Mitral Prolapse And Regurgitation for ≥60 Year-olds (PRIMARY)
for
Mitral Valve Regurgitation
Location: Portland ME, Lebanon NH, Boston MA, Quebec, Ottawa, New York NY,
Sponsor: Annetine Gelijns
Sex: All
Age: 60+
Code: NCT05051033
Recruiting
Training and Implementation of RUBI in Community Mental Health Settings
for
Autism Spectrum Disorder
Location: Augusta ME
Sponsor: Seattle Children's Hospital
Sex: All
Age: 0 - 70+
Code: NCT05742464
Recruiting
Nerve Block for Pain Control After Fracture Surgery
for
Ankle Fractures, Distal Radius Fracture
Location: Augusta ME
Sponsor: MaineGeneral Health
Sex: All
Age: 18+
Code: NCT05391464
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
By submitting, you consent to the use of your personal details, including contact information and location, to respond to your request for information related to clinical trials, as outlined in the Privacy Policy. If at any time you want to discontinue receiving alerts, please click the Unsubscribe link in the email received.
Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)
for
Immunoglobulin A Nephropathy, IgAN
Location: Augusta ME, Boston MA, Albany NY, East Setauket NY,
Sponsor: Alexion Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT06291376
Phase3, Recruiting
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
for
Advanced Malignant Solid Neoplasm,
Location: Augusta ME, South Portland ME, Scarborough ME, Brewer ME,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 70+
Code: NCT05564377
Phase2, Recruiting
A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma
for
Stage III Cutaneous Melanoma AJCC v7,
Location: Augusta ME, Lebanon NH, Boston MA, Springfield MA, Westerly RI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT02339571
Phase2, Phase3, Recruiting
Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment Trial